FLEX PHARMA INC - COM (FLKS)

CUSIP: 33938A105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
3,547,011
Share change
-1,458,939
Total reported value
$3,332,234
Price per share
$0.94
Number of holders
25
Value change
-$6,418,172
Number of buys
16
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 33938A105?
CUSIP 33938A105 identifies FLKS - FLEX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEX PHARMA INC - COM (FLKS) as of Q2 2018

As of 30 Jun 2018, FLEX PHARMA INC - COM (FLKS) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,547,011 shares. The largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, ROYCE & ASSOCIATES LP, RENAISSANCE TECHNOLOGIES LLC, Telemetry Investments, L.L.C., DEUTSCHE BANK AG\, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.